Please see below for a list of search results.
This policy sets out the legal requirements of the HT Act with regard to consent for post-mortem examination, tissue retention and storage of tissue from the deceased.
This position statement outlines guidance provided on consent for post-mortem examination and tissue retention.
The HTA licenses a number of activities relating to human tissue. We are also responsible for carrying out inspections to ensure licence conditions are being met. These activities are laid out in the Human Tissue Act and associated Regulations.
The activities licensed by the HTA are:
The Human Tissue Act covers primarily England, Wales and Northern Ireland; only section 45 and schedule 4 of the Human Tissue Act include Scotland. There is separate legislation in Scotland – the Human Tissue (Scotland) Act 2006 – and the HTA performs certain tasks on behalf of the Scottish...
Schedule 1 of the Human Tissue Act 2004 (the Act) sets out ‘performance assessment’ as a ‘scheduled purpose’.
An HTA licence is required if the human cellular material (‘relevant material’) to be stored for performance assessment has been removed from the deceased.
All establishments licensed under the Human Tissue Act 2004 and the Quality and Safety of Organs for Transplantation Regulations 2012 must complete and submit the compliance update questionnaire on the HTA portal.